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Abstract
Objective. To assess the impact of introducing clinical practice guidelines on acute coronary syndrome without persistent ST
segment elevation (ACS) on patient initial assessment.
Design. Prospective before–after evaluation over a 3-month period.
Setting. The emergency ward of a tertiary teaching hospital.
Patients. All consecutive patients with ACS evaluated in the emergency ward over the two 3-month periods.
Intervention. Implementation of the practice guidelines, and the addition of a cardiology consultant to the emergency team.
Main outcome measures. Diagnosis, electrocardiogram interpretation, and risk stratification after the initial evaluation.
Results. The clinical characteristics of the 328 and 364 patients evaluated in the emergency ward for suspicion of ACS before
and after guideline implementation were similar. Significantly more patients were classified as suffering from atypical chest pain
(39.6% versus 47.0%; P = 0.006) after guideline implementation. Guidelines availability was associated with significantly more
formal diagnoses (79.9% versus 92.9%; P < 0.0001) and risk stratification (53.7% versus 65.4%, P < 0.0001) at the end of initial
assessment.
Conclusion. Guidelines implementation, along with availability of a cardiology consultant in the emergency room had a posit-
ive impact on initial assessment of patients evaluated for suspicion of ACS. It led to increased confidence in diagnosis and
stratification by risk, which are the first steps in initiating effective treatment for this common condition.
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Among people with acute chest pain presenting to the
emergency departments of hospitals, 15% suffer from acute
coronary syndrome with persistent ST segment elevation on
the electrocardiogram (ECG) [acute myocardial infarction
(AMI)], 35% from acute coronary syndrome without persist-
ent ST segment elevation (ACS) (non-ST elevation AMI and
unstable angina), and 50% from other diseases [1]. The 1-year
mortality of ACS is ∼12%, mainly during the acute phase of
the disease [2,3]. ACS is characterized by the rupture of an
atheromatous plaque in a coronary artery, leading to throm-
bus formation [4,5], and can induce occlusion of the artery
or distal embolization. Aggressive treatment is able to stop
this process and consequently salvage some cardiac muscle
cells.
Diagnosis rests on clinical history, physical examination,
and ECG, which together allow the correct identification of
patients suffering from an acute ischemic event in 90% of
cases [6]. Stratification into different risk categories [7,8] is
useful, as prognosis is directly linked with risk categories [9]
and treatment intensity.
Blood level determination of troponin is an important
diagnostic aid in identifying low-risk patients [10] who can be
discharged early, and high-risk patients [11] who have to be
aggressively treated [12]. This test was recently introduced in
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the decision algorithm, in addition to clinical history, physical
examination, and ECG.
Practice guidelines dedicated to the assessment of patients
with ACS have existed in the United States since 1994 [13],
and have recently been published in Europe [14] and revised
in the US [15]. We designed this study to assess prospectively
the impact of introducing practice guidelines on patient initial
assessment in our institution.
Patients and methods
After a systematic review of the literature, expert physicians
from the cardiology, critical care medicine, and general
internal medicine staff met on several occasions to review
current evidence from published randomized trials and meta-
analysis of the diagnosis and treatment of ACS, as defined
above. Evidence was graded according to the recommenda-
tions of evidence-based medicine. A clinical practice guideline
was then drafted by one of us (A.B.), and validated by internal
reviewers. External reviewers, including one of the authors of
the European guidelines, provided final validation.
Before guideline implementation, all patients evaluated at
the emergency department of our institution over a 3-month
period (1 October 2000 to 31 December 2000) with acute
chest pain of <12 hours duration were considered eligible for
this study. Patients suffering from chest pain of non-cardiac
origin and AMI with permanent ST segment elevation were
registered, but excluded from the ACS group. The medical
staff at the emergency department included nine full-time res-
ident positions, three senior registrars, and additional resi-
dents or students on occasion.
For ACS patients, a research assistant (D.G.) reviewed
medical charts and collected medical history, clinical charac-
teristics, laboratory test results (including troponin I blood
levels, measured twice, 6 hours apart), and ECG interpretation
on the day following admission. Risk stratification into four
categories according to the forthcoming practice guideline [16]
was actively retrieved from emergency physicians, without
providing them with the following precise definitions:
1. Low-risk patients: acute chest pain without modification
of the ECG or laboratory tests (troponin I blood level
<0.1 µg/ml).
2. Intermediate-risk patients: acute chest pain with modifications
of the ECG (down-sloped ST segment <1 mm or negative
T-wave) and negative troponin I blood level (<0.1 µg/ml).
3. High-risk patients: prolonged chest pain (>20 minutes) or
modification of the ECG (down-sloped ST segment >1 mm)
or at least one positive troponin I blood level.
4. Very high-risk patients: acute recurrent or refractory chest
pain, or hemodynamic instability (cardiogenic shock) or
rhythmic instability, and transient ST segment elevation.
The high-risk group described in the European Society of Cardiol-
ogy (ESC) and American Heart Association (AHA) guidelines
was split into high risk and very high risk groups because different
treatment strategies, which are not available in all hospitals, are
used in our institution to treat these specific conditions.
The practice guidelines were introduced in January 2001.
Implementation strategy included presentation and distribution
of the guidelines to all internal medicine and cardiology phy-
sicians, including interns, residents, fellows, and staff physi-
cians, and educational interventions by experts in the field
during weekly seminars (small group meetings) and grand
rounds (large group meetings). During these meetings, detailed
presentation of the guidelines was carried out and all ques-
tions related to the topic were answered. A comprehensive
document summarizing the evidence was handed out [16], as
well as a one-page algorithm (Figure 1). Both documents were
also available on the intranet network. In addition, we placed
reminders in the charts of all patients diagnosed with chest pain
while in the emergency room, and posted general reminders on
the emergency residents’ office walls. At the same time, a cardio-
logy consultant, who was available during working hours 5 days
a week, was added to the emergency medical staff.
For the second part of the study, conducted after introduc-
tion of the guidelines, several strategies were used to minimize
the change in the residents’ professional behaviour induced by
the study itself (Hawthorne effect). Residents were blind to
the actual aim of the trial and were only informed that a sur-
vey on cardiovascular medicine would be conducted among
clinical patients. Furthermore, we simply announced a train-
ing program in evidence-based medicine including sessions
on several clinical topics, such as deep venous thrombosis or
community-acquired pneumonia for example.
Impact on patient initial assessment was measured following
the same methodology as described above, over a 3-month
period, extending from 1 February 2001 to 30 April 2001.
Analysis compared patient characteristics, initial assessment
characteristics, laboratory test results, ECG interpretation,
and risk stratification in the two parts of the study.
Two reviewers (A.B. and J.B.W.) separately carried out
independent risk assessments based on laboratory tests results
and ECG interpretation for all patients. The ECG interpret-
ation was based upon an independent assessment of all ECGs
by two other reviewers (P.E. and J.C.S.), blinded to the clin-
ical and patient’s characteristics, and ECG interpretation by
emergency residents, who classified them, as did the resi-
dents, into the following categories: normal, negative T-wave;
down-sloped ST segment 0.5–1.0 mm; down-sloped ST
segment >1.0 mm; and transient ST segment elevation,
corresponding to the four categories of risk mentioned above.
Disagreement between the two reviewers was resolved by a
third reviewer ( J.S.). We used this final ECG analysis for the
independent risk assessment. Concordance analysis was carried
out only for patients with available risk stratification data
and diagnosed with ACS at the end of the initial assessment.
Comparisons between the two groups were carried out
using the Student’s t-test for continuous variables (after
assessment of distribution normality), the Mann–Whitney
U-test for ordinal variables or non-normally distributed data,
and the χ2 test for distributions, as appropriate. Distribution
analyses were carried out after exclusion of missing data, and
opposing missing data to available ones. All analyses were
carried out with SPSS 12.0 for Windows. Statistical significance
was assumed at a P-value of <0.05.
Impact of ACS clinical practice guidelines
385
Depending on
clinical course
Coronarography
Functional test
Intermediate
care unit
Acetyl-salicylic
acid
Clopidogrel∗
Nitrates
Betablockers
LMW Heparin
Depending on
clinical course
(Chest pain,ECG)
Functional test
Discharge home
Observation
ward
Acetyl-salicylic
acid
Depending on
clinical course
(Chest pain,ECG)
TIROFIBAN/
EPTIFIBATIDE
Coronarography
within
2–7 days
Depending on 
clinical course 
(Chest pain,ECG)
Intensive care 
unit 
Acetyl-salicylic
acid 
Nitrates 
Betablockers 
Full dose 
anticoagulation 
Intensive care
unit
Acetyl-salicylic
acid
Nitrates
Betablockers
Full dose
anticoagulation
ABCIXIMAB
Coronarography
within
 12–24 hours
* if no coronarography
- Long lasting chest pain (>20 min.)
- Second long lasting chest pain (>20 min.)
- Associated left cardiac failure (diminished
breath sounds, third heart sound)
- Hemodynamically unstable angina
- Angina with new mitral regurgitation
Transient ST elevationST depression >1mmST depression 0,5–1mm
T wave inversion
Normal ECG
Serum troponin level
ECG
Positive Troponin
(at least 1x) OR
HIGH RISK VERY HIGH RISK
Negative Troponin (2x)
INTERMEDIATE RISKLOW  RISK
Suspicion of acute
coronary syndrome
exclusion exclusion
Diagnosis
Acute myocardial
infarction with ST
elevation on the ECG
Diagnosis
Chest pain of
non-cardiac origin
Initial assessment
- clinical history
- clinical examination
- paraclinical examination
(laboratory tests, ECG, chest X-ray)
Reperfusion strategy
Specific treatment 
Figure 1 Clinical pathway for acute coronary syndrome.
J.-B. Wasserfallen et al.
386
Results
During the two study periods, 3284 and 3260 patients, respec-
tively, were evaluated at the Medical Emergency Department
of our institution. Among them, 497 (15.1%) and 498 (15.3%)
were evaluated for chest pain, by 33 and 32 different physi-
cians, respectively. Residents contributed to 95% and 97% of
the assessments, and only four of them treated patients dur-
ing both study periods, with the majority of assessments car-
ried out during one period.
Non-cardiac origin was diagnosed in 143 (28.8%) and 109
(21.9%) patients, pre- and post-guidline implementation, res-
pectively. Clinical characteristics of these patients were not
statistically significantly different between the two study peri-
ods. One hundred and sixteen were women and 136 were men
(mean age 47 ± 20 years). Fifty per cent of them suffered from
osteo-articular problems, 21% from pulmonary diseases, 10%
from psychological disturbances, 5% from pericarditis and
myocarditis, and 2% from gastro-intestinal disorders. Finally,
unknown origin for chest pain was ascribed to 12% of them.
AMI with persistent ST elevation was diagnosed in 26
(5.2%) and 25 (5.0%) patients in the two groups, respec-
tively. Clinical characteristics of these patients were again
not different between the two study periods. Of these 51
patients (13 women and 38 men, mean age 47 ± 20 years),
42% of them suffered from anterior wall infarction, and
48% from inferior or posterior wall infarction, while 4%
were located on the right ventricle only and 6% could not be
located at all.
The remaining 328 (10.0% of all admissions in the first
period) and 364 (11.2% of all admissions in the second period)
patients were included in this study. Their main characteristics
are summarized in Table 1. The two groups were not statisti-
cally significantly different.
Table 1 ACS patients’ characteristics
Before guidelines After guidelines P-value
........................................................................................................................................................................................................................
Total patient number 328 364
Women, n (%) 142 (43.3) 149 (40.9) 0.531
Men, n (%) 186 (56.7) 215 (59.1)
Mean age (SD) 61.7 (17.8) 63.0 (17.0) 0.313
Cardiac history, n (%) 131 (39.9) 135 (37.1) 0.365
Risk factors, n (%) 0.685
Family history 89 (27.1) 57 (15.7)
Hypercholesterolemia 156 (47.6) 162 (44.5)
Diabetes mellitus 41 (12.5) 46 (12.6)
Hypertension 176 (53.7) 173 (47.5)
Smoking 92 (28.0) 111 (30.5)
Pain characteristics, n (%) 0.193
Thoracic oppression 183 (55.8) 183 (50.3)
Atypical 130 (39.6) 171 (47.0)
Not specified 15 (4.6) 10 (2.7)
Duration in minutes
Mean (SD) 81.7 (86.8) 100.5 (100.5) 0.074
Median (25, 75 percentiles) 60.0 (30.0, 120.0) 60.0 (25.0, 120.0)
Intensity upon admission
Mean (SD) 4.7 (2.1) 4.8 (2.3) 0.916
Median (25, 75 percentiles) 5.0 (3.0, 6.0) 5.0 (3.0, 6.0)
Maximal intensity
Mean (SD) 6.7 (2.1) 6.3 (2.2) 0.107
Median (25, 75 percentiles) 7.0 (5.0, 8.0) 6.0 (5.0, 8.0)
Vital signs (SD)
Systolic blood pressure
Mean (SD) 147.2 (25.7) 145.3 (24.8) 0.310
Median (25, 75 percentiles) 147.0 (130.0, 161.0) 146.0 (126.2, 160.0)
Diastolic blood pressure
Mean (SD) 86.1 (14.7) 85.6 (15.6) 0.710
Median (25, 75 percentiles) 86.0 (76.0, 96.0) 86.0 (75.0, 95.0)
Heart rate
Mean (SD) 82.0 (21.7) 83.2 (21.6) 0.484
Median (25, 75 percentiles) 78.5 (67.0, 93.0) 79.5 (69.0, 94.7)
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Results of the initial assessment are shown in Table 2.
Although vital signs, mean duration, and maximal intensity of
chest pain did not change significantly, significantly more
patients were considered as having atypical chest pain at the
end of the initial assessment after implementation of the
guidelines [120 patients (47.0%) compared with 154 patients
(39.6%); P = 0.002). In addition, ECG description was more
often classified as abnormal. Troponin I blood level results
were less often under the detection limit. These findings sug-
gest a lower diagnostic threshold, but a better targeting of the
use of diagnostic tests after guideline implementation than
before.
The most important changes after guideline implement-
ation were the clinician’s commitment in assessing the prob-
ability of coronary heart disease (94.8% compared with 82.9%
pre-implementation), in stratifying patients by risk of coro-
nary event (65.4% versus 53.7%), and in making a diagnosis at
the end of the initial assessment (92.9% versus 79.9%). The
number of missing values dropped significantly in these three
variables (P < 0.0001).
Comparison of the risk stratification of patients performed
by the clinicians and the reviewers at the end of the initial
assessment showed significantly less differences after guide-
line implementation than before (Table 3). Data were avai-
lable for 87.8% of the patients before and 97.2% after
guideline implementation. Concordance was observed in
20.8% and 42.0% of cases, respectively. Discrepancies were
limited to one level of risk in 59.4% of cases before and
44.2% after guideline implementation, with overestimation of
risk by clinicians in 64.4% and 43.4% of cases, respectively.
Conversely, underestimation of risk by clinicians was recorded
in 14.8% and 14.5% of cases, respectively.
Discussion
This prospective study showed that clinical practice guide-
lines for evaluation and treatment of ACS had a partial but
positive impact on patient assessment. The study populations
before and after guideline implementation were not statisti-
cally significantly different, but their assessment at the emer-
gency department was quite different. Particularly striking
were the apparent decrease in relative importance of history
characteristics in favour of ECG and troponin blood level
results in attributing a patient to a specific risk category. This
might be ascribed to the impact of the decision algorithm that
summarized the clinical practice pathway.
Also striking was the increased commitment of physicians
in the assessment of the probability of underlying coronary
artery disease, patient risk stratification, and diagnosis at the
Table 2 Results of the initial assessment
Before guidelines, n (%) After guidelines, n (%) P-value
........................................................................................................................................................................................................................
Total n 328 364
Electrocardiogram 0.971
Normal 149 (45.4) 173 (47.5)
Abnormal 149 (45.4) 172 (47.4)
Assessment not available 30 (9.2) 26 (7.1)
Troponine T blood level 0.003
<0.03 µg/ml 265 (80.8) 254 (69.8)
0.03–0.09 µg/ml 28 (8.5) 67 (18.4)
>0.1 µg/ml 35 (10.7) 43 (11.8)
Presence of coronary heart disease 0.356
Yes 163 (49.7) 194 (53.3)
No 109 (33.2) 151 (41.5)
Assessment not available 56 (17.1) 19 (5.2) <0.0001
Risk of coronary event <0.0001
Small 40 (12.2) 106 (29.1)
Intermediate 50 (15.2) 55 (15.1)
High 64 (19.5) 51 (14.0)
Very high 22 (6.7) 26 (7.1)
Assessment not available 152 (46.3) 126 (34.6) 0.002
Diagnosis 0.646
Atypical chest pain 120 (36.6) 154 (42.3)
Probable unstable angina 98 (29.9) 118 (32.4)
Unstable angina 17 (5.2) 24 (6.6)
Myocardial infarction 14 (4.3) 16 (4.4)
Other diagnosis 13 (4.0) 26 (7.1)
Assessment not available 66 (20.1) 26 (7.1) <0.0001
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time of the initial evaluation. This influence is likely to be
ascribed to the availability of risk classification for immediate
use at the bedside.
Moreover, the ACS guidelines’ positive impact on diminish-
ing diagnostic uncertainty must be emphasized, as initial assess-
ment is the cornerstone for allocating patients to specific
treatment and monitoring. Any intervention conducted to
decrease the delay in reaching the appropriate diagnosis and
starting treatment is likely to have a positive impact on patient
outcome. On the other hand, it should also result in a better use
of scarce resources, such as expensive treatment procedures or
intensive monitoring facilities, by reducing both over- and under-
treatment, which both might negatively affect patient outcome.
This study did, however, show important limits in compli-
ance with the guidelines’ recommendations. The first one was
related to the use of troponin blood level determination.
Although results of the test during the second part of the
study were more often located above the detection threshold,
or positive, suggesting a better targeting of patients, its use
was not optimal. In particular, the recommended second tro-
ponin blood level determination in case of a negative first one
was seldom carried out (35%). This might be explained by the
fact that this kind of test had just been introduced in our insti-
tution, and that physicians still lacked expertise in using it.
The second limit is the relatively small improvement in accu-
rate risk stratification in these patients, as demonstrated by a
low level of agreement between clinicians and experts. This is
possibly due to the fact that the concept of risk stratification
was new for most of them. The finding that risk was over-
estimated in most discrepant assessments suggests that emer-
gency room physicians might be overcautious in taking care
of these patients, and might prefer over-treatment and unnec-
essary monitoring to under-treatment and overlooking moni-
toring. Further intervention is clearly needed to improve the
routine use of risk stratification and its confident assessment,
and longer follow-up necessary to assess the impact of the
learning curve effect linked with the residency program.
This study provided yet another example of the difficulty
of improving clinical care, even when evidence is brought to
the bedside. This had already been demonstrated with the
first version of the US guidelines: their introduction increased
the percentage of patients treated with the recommended
drugs such as aspirin or beta-blockers, and decreased the
number of patients on calcium antagonists [17,18]. Another
study carried out in Australia failed to show such a clear
impact on drug use [19]. Altogether, a single study showed
that patients’ survival improved after guideline implement-
ation [20]. On the other hand, such guidelines were designed
to ease the orientation of low-risk patients to outpatient care,
and high-risk patients to intensive care units. With respect to
this, they partly missed their goals: low-risk patients were not
treated as outpatients, and hospitalizations did not decrease,
but at the same time an increased demand for intensive care
beds was noted, which would require additional resources for
no proven survival benefit [21]. Finally, guidelines were
incompletely applied to elderly patients, and quality of care
varied widely between hospitals [22]. Cardiologists were more
likely to apply them than general internal medicine specialists,
with no differences in patient outcome [23].
These findings points out the necessity of careful assessment
of both processes of care and patient outcomes when an inter-
vention is implemented in the health care system, in particular
the introduction of clinical practice guidelines. In addition, local
adaptation of international guidelines is expensive, and not in
itself a guarantee that they will be applied [24].
This study has obvious limitations: firstly, it involved only
one centre; secondly, it did not extend to assessing patient
outcome; thirdly, the impact of the practice guidelines was
assessed shortly after their implementation, and was not
repeated later; and fourthly, the emergency room teams at the
times of the two study periods were different. However, the
study’s findings are in perfect agreement with those described
in the medical literature [17,22]. They will serve as a basis for
additional interventions aimed at continuous quality improve-
ment in our setting. These findings underline the importance
of pre-testing guidelines by explicitly quantifying the risks and
benefits of standardizing care in ACS, which has been shown
to exhibit wide practice variations between hospitals and
Table 3 Concordance of risk stratification between emergency room physicians and reviewers
..............................................................................................................................................................................
ER physician
...................................................................................
Risk before guideline implementation (n)
..................................................................................
Risk after guideline implementation (n)
Low Moderate High Very high Total Low Moderate High Very high Total
........................................................................................................................................................................................................................
Reviewer Risk (n)
Low 0 23 17 2 42 25 25 13 1 64
Moderate 1 8 15 2 26 6 10 9 0 25
High 1 7 13 6 27 1 4 17 12 34
Very high 0 0 6 0 6 0 4 5 6 15
Total 2 38 51 10 101 32 43 44 19 138
Kappa −0.05 0.219
Statistical significance 0.301 <0.001
Impact of ACS clinical practice guidelines
389
between countries [1,25]. These findings will also be used to
model the costs and thus the resources needed to anticipate
improved compliance with the guidelines, once barriers to their
implementation are addressed [26], so that patient safety can
be guaranteed by appropriate monitoring when high-risk drugs
and procedures are used to treat them.
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